SAN DIEGO / Aug 29, 2025 / Business Wire / Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Company will present at the following investor conferences in September.
Cantor Global Healthcare Conference | |
| |
Date / Time: | September 3rd, at 9:10 AM ET |
Format: | Fireside Chat & 1x1’s |
Location: | New York, NY |
Webcast Link: | |
Wells Fargo Healthcare Conference | |
| |
Date / Time: | September 4th |
Format: | 1x1’s |
Location: | Boston, MA |
H.C. Wainwright 27th Annual Global Healthcare | |
| |
Date / Time: | September 9th, at 8:00 AM ET |
Format: | Fireside Chat & 1x1’s |
Location: | New York, NY |
About Gossamer Bio
Gossamer Bio is a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Its goal is to be an industry leader in, and to enhance the lives of patients living with, pulmonary hypertension.
| Last Trade: | US$2.19 |
| Daily Change: | -0.12 -5.19 |
| Daily Volume: | 2,724,691 |
| Market Cap: | US$501.250M |
September 25, 2025 September 22, 2025 August 05, 2025 June 16, 2025 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
